投稿ビュー
Amarin's Fish-Oil-Derived Drug Shows Great Promise — With Big Caveats - Forbes
Forbes | Amarin's Fish-Oil-Derived Drug Shows Great Promise — With Big Caveats Forbes Vascepa, a fish-oil-derived heart drug, reduced the risk of dying from a heart attack or stroke in a major clinical trial, potentially providing a big benefit for patients and a boost to its maker, Amarin Pharmaceuticals of Bedminster, N.J., which ... Data on Fish-Oil Pill May Justify Amarin's Surging Stock Price Detailed results show Amarin fish oil drug offered a major cardiovascular benefit — but come with a blemish Deeper Dive: Amarin Fish-Oil Study Gives Eager Doctors More to Ponder |
投稿情報
評価
おすすめ
タグ
転職
"
"@type":
"@type":"NewsArticle"
"Auga Group"
"C" grade Nevada infrastructure
"Errol Oh"
"Jane Goodyear"
"Optimistically Cautious"
"a man and his prostate"
"akcijų pardavimas"
"analytics:simplereach:id":"54
"author":"Art Berman"
"author":"Brad McMillan"
"author":"Bryan Rich"
"author":"Christopher Helman"
"author":"Claire Poole"
"author":"Clare O'Connor"
"author":"David Blackmon"